R A Hock
Overview
Explore the profile of R A Hock including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
307
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hock R, Curry J
J Youth Adolesc
. 2013 Dec;
12(6):461-70.
PMID: 24306447
The historical view of masculinity/femininity posited essentially bipolar opposites, with the presence of one set of characteristics precluding the other. More recent studies of sex-role stereotypes have defined sexual orientation...
2.
Heuer J, Hock R
J Immunother
. 1999 Jul;
22(4):324-35.
PMID: 10404434
Retroviral constructs were designed to express the novel cytokine interleukin 18 (IL-18), also known as interferon-gamma-inducing factor, in a murine neuroblastoma cell line [neuro-2a (N-2a)] to examine the effects of...
3.
Hunt C, Sim J, Sullivan S, Featherstone T, Golden W, Hock R, et al.
Cancer Res
. 1998 Sep;
58(17):3986-92.
PMID: 9731512
Chronic exposure (>200 days) of HA1 fibroblasts to increasing concentrations of H2O2 or O2 results in the development of a stable oxidative stress-resistant phenotype characterized by increased cellular antioxidant levels,...
4.
Hanenberg H, Hashino K, Konishi H, Hock R, Kato I, Williams D
Hum Gene Ther
. 1998 Feb;
8(18):2193-206.
PMID: 9449373
Efficient retroviral gene transfer into hematopoietic stem and progenitor cells can be achieved by co-localizing retrovirus and target cells on specific adhesion domains of recombinant fibronectin (FN) fragments. In this...
5.
Heuer J, GONIN R, Hock R
Hum Gene Ther
. 1996 Nov;
7(17):2059-68.
PMID: 8934220
The T cell co-stimulatory molecule B7-1 was transduced into a poorly immunogenic murine neuroblastoma cell line (Neuro-2a, N-2a) alone or in combination with MHC class II genes to test the...
6.
Hock R, Reynolds B, Heuer J
Cancer Gene Ther
. 1996 Sep;
3(5):314-20.
PMID: 8894250
Malignant tumors express tumor-related antigens, but effective antitumor immunity does not occur in the primary host. One hypothesis is that there is insufficient stimulation of T-cell responses due to ineffective...
7.
Hock R, Reynolds B, Kwok W
J Immunother Emphasis Tumor Immunol
. 1995 Jan;
17(1):12-8.
PMID: 7728302
Immunological recognition of transformed cells is critically important to limit tumor development and proliferation. Because established tumors have escaped immune recognition and elimination, novel strategies to enhance antitumor immunity have...
8.
Osborne W, Hock R, Kaleko M, Miller A
Hum Gene Ther
. 1990 Jan;
1(1):31-41.
PMID: 2081183
Three retroviral vectors, containing a human adenosine deaminase (ADA) cDNA linked to either the simian virus 40 (SV40) early promoter, the human cytomegalovirus (CMV) immediate early promoter, or the Moloney...
9.
Hock R, Miller A, Osborne W
Blood
. 1989 Aug;
74(2):876-81.
PMID: 2752148
Adenosine deaminase (ADA) deficiency is associated with a fatal severe combined immunodeficiency. Because most patients do not have a suitable marrow donor, the introduction of a normal ADA gene into...
10.
Kwok W, Schwarz D, Nepom B, Hock R, Thurtle P, Nepom G
J Immunol
. 1988 Nov;
141(9):3123-7.
PMID: 2844907
Retroviral vectors with an internal cytomegalovirus major immediate-early gene enhancer/promoter regulating HLA class II gene expression were used to transfer HLA cDNA into human EBV-transformed B-lymphoblastoid cell lines. HLA-DQ2 beta...